These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 37091671)

  • 1. A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota.
    Xue P; Sang R; Li N; Du S; Kong X; Tai M; Jiang Z; Chen Y
    Front Cell Infect Microbiol; 2023; 13():1119037. PubMed ID: 37091671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Resistance and Microbiota Response.
    Santacroce L; Di Domenico M; Montagnani M; Jirillo E
    Curr Pharm Des; 2023; 29(5):356-364. PubMed ID: 36537602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression.
    Li B; Xu M; Wang Y; Feng L; Xing H; Zhang K
    J Ethnopharmacol; 2023 Mar; 303():116038. PubMed ID: 36529248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine.
    Yue B; Zong G; Tao R; Wei Z; Lu Y
    Phytother Res; 2022 Nov; 36(11):4125-4138. PubMed ID: 36100366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.
    Zhu LR; Li SS; Zheng WQ; Ni WJ; Cai M; Liu HP
    Front Immunol; 2023; 14():1086078. PubMed ID: 36817459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonization resistance against multi-drug-resistant bacteria: a narrative review.
    Le Guern R; Stabler S; Gosset P; Pichavant M; Grandjean T; Faure E; Karaca Y; Faure K; Kipnis E; Dessein R
    J Hosp Infect; 2021 Dec; 118():48-58. PubMed ID: 34492304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation.
    Ponziani FR; Zocco MA; D'Aversa F; Pompili M; Gasbarrini A
    World J Gastroenterol; 2017 Jul; 23(25):4491-4499. PubMed ID: 28740337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut Microbiota and Traditional Chinese Medicine: A New Clinical Frontier on Cancer.
    Chen YZ; Yuan MY; Chen YL; Zhang X; Xu XT; Liu SL; Zou X; Tao JL; Qiang YH; Wu J; Sun QM
    Curr Drug Targets; 2021; 22(11):1222-1231. PubMed ID: 33845736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome signatures and host colonization with multidrug-resistant bacteria.
    Isles NS; Mu A; Kwong JC; Howden BP; Stinear TP
    Trends Microbiol; 2022 Sep; 30(9):853-865. PubMed ID: 35184972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the gut microbiome in the development and transfer of antibiotic resistances].
    Appel TM; Vehreschild MJ
    Inn Med (Heidelb); 2022 Oct; 63(10):1043-1050. PubMed ID: 36048186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota.
    Jia Q; Wang L; Zhang X; Ding Y; Li H; Yang Y; Zhang A; Li Y; Lv S; Zhang J
    Pharmacol Res; 2020 Jan; 151():104552. PubMed ID: 31747557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes.
    Chen Y; Wang M
    Drug Des Devel Ther; 2021; 15():4849-4863. PubMed ID: 34876807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine.
    Li J; Li D; Chen Y; Chen W; Xu J; Gao L
    Clin Interv Aging; 2023; 18():963-986. PubMed ID: 37351381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The linkage of gut microbiota and the property theory of traditional Chinese medicine (TCM): Cold-natured and sweet-flavored TCMs as an example.
    Yang Y; Wu C
    J Ethnopharmacol; 2023 Apr; 306():116167. PubMed ID: 36641107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial peptide production in response to gut microbiota imbalance.
    Cardoso MH; Meneguetti BT; Oliveira-Júnior NG; Macedo MLR; Franco OL
    Peptides; 2022 Nov; 157():170865. PubMed ID: 36038014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Chinese medicines (TCMs) with varied meridians (Gui-Jing) differentially alleviate the adverse impact of Coptis chinensis on gut microbiota.
    Yang Y; Su W; Zang C; Tan Y; Zhang Y; Zhou Z; Lu W; Wu S; Zhang X; Wu C
    J Ethnopharmacol; 2023 May; 307():116256. PubMed ID: 36791931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota: A new target of traditional Chinese medicine for insomnia.
    Feng W; Yang Z; Liu Y; Chen R; Song Z; Pan G; Zhang Y; Guo Z; Ding X; Chen L; Wang Y
    Biomed Pharmacother; 2023 Apr; 160():114344. PubMed ID: 36738504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine.
    Wang L; Peng F; Peng C; Du JR
    Am J Chin Med; 2021; 49(3):609-626. PubMed ID: 33683187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria.
    Wuethrich I; W Pelzer B; Khodamoradi Y; Vehreschild MJGT
    Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33870869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.